Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Kioxia shares rise as much as 5.8% after reports that it plans to build a new chipmaking plant in northern Japan, as chipmaker Nvidia identified memory hardware shortages as a key issue in their earnings report. 
- Z.AI shares jumped as much as 8.6% after the Chinese AI company confirmed it’s responsible for the Ox Alpha AI model that swept to the top of online usage charts this weekend. 
- Hainan Jinpan shares tumble alongside other Chinese energy stocks after President Donald Trump moved to restrict some foreign-made transformers and other critical energy equipment from US grids on national security grounds.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Kioxia shares rise as much as 5.8% after reports that it plans to build a new chipmaking plant in northern Japan, as chipmaker Nvidia identified memory hardware shortages as a key issue in their earnings report. - Z.AI shares jumped as much as 8.6% after the Chinese AI company confirmed it&rsquo;s responsible for the Ox Alpha AI model that swept to the top of online usage charts this weekend. - Hainan Jinpan shares tumble alongside other Chinese energy stocks after President Donald Trump moved to restrict some foreign-made transformers and other critical energy equipment from US grids on national security grounds.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Kioxia Jumps, Z.AI Surges, Hainan Jinpan Falls

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d4f4522f-a2ab-494c-9c48-b4b3006759a2/transcript

Today’s biggest winners and losers in the stock market. 

On this episode of Stock Movers: 
Shares of Nvidia (NVDA) soared in late trading after the chipmaker at the heart of the artificial intelligence boom gave a bullish sales outlook for 2028, easing concerns that an AI spending surge is losing momentum. “We expect to grow revenue by approximately 70% in fiscal 2028,” Chief Financial Officer Colette Kress said during a post-earnings conference call. Analysts have projected a rise of about 45% for that year, according to data compiled by Bloomberg. Moreover, Nvidia would be growing even faster if it had access to more supplies, she said. “Incredibly, we are seeing demand acceleration even at our scale,” she said. “Customers’ forecasts point to our growth doubling next year.” 
Shares of Crowdstrike (CRWD) rose Wednesday on a strong financial report that saw it forecast revenue figures for the full year that exceeded analysts’ estimates, evidence that the cybersecurity industry continues to see demand driven by threats from artificial intelligence. Revenue for the third quarter will be as high as $1.53 billion, the Austin-based security software firm said in a statement Wednesday. Analysts, on average, estimated $1.52 billion, according to estimates compiled by Bloomberg. The company forecast annual revenue of $5.99 billion to $6.01 billion, ahead of estimates of $5.94 billion. 
Shares of Salesforce (CRM) soared in extended trading, after the software company gave an outlook for strong revenue expansion and deepened its partnership with Anthropic PBC, reassuring investors that it can compete successfully in the AI era. Sales will be about $11.5 billion in the fiscal third quarter, which ends in October, Salesforce said Wednesday in a statement. That’s just ahead of analysts’ average estimates, according to data compiled by Bloomberg. Current remaining performance obligations — a measure of future sales — will increase about 14%, also ahead of the average estimate of 13% growth.

Today&rsquo;s biggest winners and losers in the stock market.&nbsp;
On this episode of Stock Movers:&nbsp;
<ul>
<li>Shares of Nvidia (NVDA) soared in late trading after the chipmaker at the heart of the artificial intelligence boom gave a bullish sales outlook for 2028, easing concerns that an AI spending surge is losing momentum. &ldquo;We expect to grow revenue by approximately 70% in fiscal 2028,&rdquo; Chief Financial Officer Colette Kress said during a post-earnings conference call. Analysts have projected a rise of about 45% for that year, according to data compiled by Bloomberg. Moreover, Nvidia would be growing even faster if it had access to more supplies, she said. &ldquo;Incredibly, we are seeing demand acceleration even at our scale,&rdquo; she said. &ldquo;Customers&rsquo; forecasts point to our growth doubling next year.&rdquo;&nbsp;</li>
<li>Shares of Crowdstrike (CRWD) rose Wednesday on a strong financial report that saw it forecast revenue figures for the full year that exceeded analysts&rsquo; estimates, evidence that the cybersecurity industry continues to see demand driven by threats from artificial intelligence. Revenue for the third quarter will be as high as $1.53 billion, the Austin-based security software firm said in a statement Wednesday. Analysts, on average, estimated $1.52 billion, according to estimates compiled by Bloomberg. The company forecast annual revenue of $5.99 billion to $6.01 billion, ahead of estimates of $5.94 billion.&nbsp;</li>
<li>Shares of Salesforce (CRM) soared in extended trading, after the software company gave an outlook for strong revenue expansion and deepened its partnership with Anthropic PBC, reassuring investors that it can compete successfully in the AI era. Sales will be about $11.5 billion in the fiscal third quarter, which ends in October, Salesforce said Wednesday in a statement. That&rsquo;s just ahead of analysts&rsquo; average estimates, according to data compiled by Bloomberg. Current remaining performance obligations &mdash; a measure of future sales &mdash; will increase about 14%, also ahead of the average estimate of 13% growth.</li>
</ul>

Nvidia Rallies Post-Earnings, Crowdstrike Jumps, Salesforce Soars

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/5b72d95a-af2d-4991-ba22-b4b20161893d/transcript

Today’s biggest winners and losers in the stock market. 

On this episode of Stock Movers: 
Shares of Meta Platforms (META) gained ahead of the Wednesday close after the social media giant said it agreed to pay up to $18 billion in landmark settlements to resolve legal claims from US states that would require the company to make major changes to how it operates platforms like Facebook and Instagram. Key parts of the deal, disclosed in a court filing Wednesday, require the company to put new guardrails on its platforms, including restricting how much time youths can scroll and preventing them from switching off certain safety settings without parental consent.
Shares of Nvidia (NVDA) moved lower ahead of the company’s latest earnings report. Investors are eagerly awaiting Nvidia’s numbers for clues on what they mean to the artificial-intelligence trade and the market itself. Analysts project that revenue nearly doubled from a year ago, which would be the fastest pace in two years, according to data compiled by Bloomberg.
Shares of Revolution Medicines Inc. (RVMD) gained in the Wednesday session after the FDA approved the firm’s once-daily tablet for adults with metastatic pancreatic cancer, the first medicine to target one of the key molecular causes of the disease. The drug, which will be called Rasonque, is one of the more significant breakthroughs in pancreatic cancer in years. In a final stage trial published in May, daraxonrasib nearly doubled typical survival time for patients with an aggressive form of the disease to 13.2 months, compared with 6.7 months for patients who received chemotherapy, the current standard of care, according to the US Food and Drug Administration.

Today&rsquo;s biggest winners and losers in the stock market.&nbsp;
On this episode of Stock Movers:&nbsp;
<ul>
<li>Shares of Meta Platforms (META) gained ahead of the Wednesday close after the social media giant said it agreed to pay up to $18 billion in landmark settlements to resolve legal claims from US states that would require the company to make major changes to how it operates platforms like Facebook and Instagram. Key parts of the deal, disclosed in a court filing Wednesday, require the company to put new guardrails on its platforms, including restricting how much time youths can scroll and preventing them from switching off certain safety settings without parental consent.</li>
<li>Shares of Nvidia (NVDA) moved lower ahead of the company&rsquo;s latest earnings report. Investors are eagerly awaiting Nvidia&rsquo;s numbers for clues on what they mean to the artificial-intelligence trade and the market itself. Analysts project that revenue nearly doubled from a year ago, which would be the fastest pace in two years, according to data compiled by Bloomberg.</li>
<li>Shares of Revolution Medicines Inc. (RVMD) gained in the Wednesday session after the FDA approved the firm&rsquo;s once-daily tablet for adults with metastatic pancreatic cancer, the first medicine to target one of the key molecular causes of the disease. The drug, which will be called Rasonque, is one of the more significant breakthroughs in pancreatic cancer in years. In a final stage trial published in May, daraxonrasib nearly doubled typical survival time for patients with an aggressive form of the disease to 13.2 months, compared with 6.7 months for patients who received chemotherapy, the current standard of care, according to the US Food and Drug Administration.</li>
</ul>

Meta Gains on Settlement, Nvidia Dips Ahead of Earnings, RevMed Rallies 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/94e4bcf2-12fc-47f4-9833-b4b2014141e3/transcript

Abercrombie & Fitch (ANF) shares soar. Abercrombie & Fitch shares jump as much as 30% to trade at their highest intraday level since January 2025 after the apparel retailer raised its adjusted earnings per share guidance for the full year.

-J M Smucker (SJM) raised its full-year outlook for sales and profit, buoyed by growth in its Uncrustables sandwiches and coffee. The packaged food company said it now expects adjusted earnings per share for fiscal 2027 of between $10.50 and $11.00, up from its prior estimate of $9.75 to $10.25. Smucker expects net sales to fall 1% to 2%, an improvement over its previous forecast of a decline of 3% to 4%. 

-Zoom Communications (ZM) shares fall. The software company’s second-quarter results were seen as mixed. It also gave outlooks for adjusted third-quarter earnings and operating income that were weaker than expected. 

Abercrombie &amp; Fitch (ANF) shares soar. Abercrombie &amp; Fitch shares jump as much as 30% to trade at their highest intraday level since January 2025 after the apparel retailer raised its adjusted earnings per share guidance for the full year.
-J M Smucker (SJM) raised its full-year outlook for sales and profit, buoyed by growth in its Uncrustables sandwiches and coffee. The packaged food company said it now expects adjusted earnings per share for fiscal 2027 of between $10.50 and $11.00, up from its prior estimate of $9.75 to $10.25. Smucker expects net sales to fall 1% to 2%, an improvement over its previous forecast of a decline of 3% to 4%.&nbsp;
-Zoom Communications (ZM) shares fall. The software company&rsquo;s second-quarter results were seen as mixed. It also gave outlooks for adjusted third-quarter earnings and operating income that were weaker than expected.&nbsp;

Abercrombie & Fitch Soars, J M Smucker Rises, Zoom Communications Falls as Tepid Outlook Offsets AI Monetization

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/230a8354-1fa7-46a6-9a2e-b4b200fb50aa/transcript

Kioxia Jumps, Z.AI Surges, Hainan Jinpan Falls

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips